Soteria Biotherapeutics is based in San Francisco. It has raised $42M in total funding. Latest round: Series A.
Soteria Biotherapeutics is based in San Francisco. Soteria Biotherapeutics has raised $42M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2021. The round record for Soteria Biotherapeutics runs through 2021; nothing later has been disclosed. Investors on record include Roche Venture Fund, 5AM Ventures, M Ventures, Novartis Venture Fund, Alexandria Venture Investments, Aglaia BioMedical Ventures and 4 others. 10 distinct backers are named across the disclosed rounds.
Totals shown for Soteria Biotherapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in San Francisco and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026